GalenOps prod · 0.1.0

Patients

2

Active

0

enrolled or consented

Withdrawn

2

Serious AEs

0

Open QA findings

0

Aged data queries

1

Studies & contracts

total budget 64000.00 USD

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma
Phase II study completed contract executed 64000 USD

Patients first 2

RefStatusConsentedStudy
P2B-016 withdrawn 2012-07-08 A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma
P2B-077 withdrawn 2013-02-17 A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma

Luna participants 0

No Luna participants yet

Participants at this site have not been invited to Luna.

Safety

5 AEs · 0 serious

No serious adverse events at this site

Non-serious events are listed under Data & Safety.

QA findings

0 open

No findings recorded

Findings are filed by monitoring visits.

Monitoring visits 0

No visits recorded

Re-score risk to propose an on-site visit.

Payments 0

No payments on file

Milestone payments are proposed by the finance step and approved in the review queue.